Elysium

formerly Elysium Health

Elysium is a life sciences company in New York, United States, founded in 2014. It has raised $71.5M across 5 rounds, most recently a $283K Grant in June 2023.

Start your longevity routine

Headquarters
New York, New York
Employees
11–50
Founded
2014
Business Model
B2C
Total Funding
$71.5M
Last Round
$283K GrantJun 2023
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 5 investors for this company. The full record is or through the API.

About

Elysium Health is a longevity science company founded in 2014 and headquartered in New York. The company translates critical scientific advancements in aging research into accessible health products and technologies, working with over 25 world-renowned scientists and clinicians. Its flagship product, Basis, is a clinically studied NAD+ supplement designed to support cellular energy, healthy DNA maintenance, and the aging process. Elysium also offers a biological age test called Index, alongside additional supplements targeting metabolic aging, collagen, brain health, and immune support. The company has conducted 16+ completed and ongoing human clinical trials and maintains research collaborations with Oxford and Yale.

Summary

It lists 11–50 employees. It has raised $71.5M in total across 5 rounds, most recently a $283K Grant round in Jun 2023. Investors include General Catalyst, Morningside Group and Breyer Capital.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSTTR Phase I (NIH)Jun 2023
$283K

Sign up to see all 7 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Elysium on Indexed.vc
<a href="https://indexed.vc/companies/elysium"><img src="https://indexed.vc/api/badge/company/elysium" alt="Elysium on Indexed.vc" width="260" height="76" /></a>